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( i ) 
SUMMARY 
The aim of t h i s work was the preparation of a se r i e s of com-
pounds having similar s t r u c t u r a l features to the highly active neuro-
muscular blocking agent ( i ) . 
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I n view of the current i n t e r e s t i n diquaternary tetrazenes as 
short-acting non-depoLirising neuromuscular blocking agents,, the syn-
thesis of the diquaternary s a l t s ( i i ) incorporating two 2-methylamino-
pyridine units joined by an azo l i n k , and the diquaternary s a l t s ( i i i ) -
( v i ) incorporating two imidazo £l,E>-a J pyridine heterocyclic systems 
joined by an azo l i n k was undertaken. 
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DIQQATERNARY COMPOUNDS CONTAINING THE 2-METHYLAMINOPYRIDINE SYSTEM AND 
A TETRAZENE LINKAGE ( i i ) 
Attempted synthesis of the diquaternary tetrazene ( i i ) by the 
methylation of the tetrazene base ( v i i ) gave the tetrazolopyridinium 
s a l t ( v i i i ) . 
AJ Me r N N N o e N — // 
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C y c l i s a t i o n of tetrazene ( v i i ) to the tetrazolopyridinium 
bromide ( v i i i j X = Br) was also effected by boil i n g ethanolic hydro-
bromic acid and the i s o l a t i o n of 2-methylaminopyridlne from such a 
c y c l i s a t i o n confirmed the mechanism as shown below. 
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DIQUATERNARY COMPOUNDS CONTAINING IMIDAZo[l,5-a] PYRIDINE HETEROCYCLIC 
SYSTEMS AND A TETRAZME LINKAGE ( i i i ) - ( v i ) 
The attempted synthesis of diquaternary tetrazenes ( i i i ) - ( v i ) 
by the oxidation of the N-amino s a l t s ( x i i i ) - ( x v i ) , with saturated 
aqueous bromine gave the respective l,2-dihydroazeto^l J2-a] pyridinium 
bromides ( x v i i ) - (xx). The N-amino s a l t s ( x i i i ) - (xvi) were obtained 
by treating the parent imidazojlL,3>-aJ pyridines ( i x ) - ( x i i ) with 
0-p-to]ylsulphonylhyc"roxylamine. 
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The suggested course of reaction i s v i a i n i t i a l bromination 
at the free position of the imidazo ring followed by oxidation of the 
amino function yielding the amino nitrene ( x x i ) . The 1,U addition of 
bromine i n the f i v e me:iribered ring followed by nitrogen loss then gives 
the l,2-dihydroazetoll,2-a I pyridinium bromide as shown below. 
Br Br 
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(v) 
Hydrogenation of the tribromo-2-phenyldihydroazetopyridinium s a l t 
( x v i i i ) over palladium charcoal resulted i n the uptake of approximately 
two molecular equivalents of hydrogen and subsequent b a s i f i c a t i o n gave 
phenyl-2-pyridylmeth3'-lketone ( x x i i i ) presumably v i a the intermediate 
monobromo compound (jcxii) as shown below. 
Br c Br n OH OH Br Br 
Ph Ph Ph 
( x x i i ) ( x v i i i ) 
CHoCOPh rr N 
( x x i i i ) 
(vi) 
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INTRODUCTION 
NEUROMUSCULAR BLOCKING AGENTS 
Neuromuscu3.ar blocking agents interrupt the normal operation 
of the nerve-voluntary muscle transmission at the neuromuscular junc-
tion. Also they can a f f e c t the conduction of the nerve impulse along 
the motor axons, but they do not af f e c t the contractile power of the 
muscle^. 
PHYSIOLOGY OF NEUROMUSCULAR TRANSMISSION 
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IHEUROMQSCULAR JUNCTION 
1 
I t i s possible to measure the potential difference i n various c e l l s 
and muscles, by using microelectrodes. The resting potential of a 
muscle varies from one organism to another and i s generally i n the 
range 60 - 90 mV, with the inside invariably being negative with 
respect to the outer surface. Such potentials remain stable for 
long periods of time, so long as no impulse i s t r a v e l l i n g through the 
o 
muscle . 
Stimulation of the muscle membrane r e s u l t s i n the inner sur-
face becoming approadmately 10 mV positive (end plate potential) due 
to a temporary increase i n the permeability of the muscle membrane to 
sodium ions which pass through the membrane from the e x t r a c e l l u l a r 
f l u i d ^ . This l o c a l i s e d area of depolarisation produces an outward 
current flow into the adjacent polarised membrane, res u l t i n g i n i t s 
depolarisation^. This wave of depolarisation and repolarisation i s 
propagated along the; muscle and i s known as the muscle action poten-
t i a l and i t causes contraction of the muscle. On removal of the 
stimulus, the muscle; regains i t s polarisation i n i t i a l l y by the out-
ward flow of i n t r a c e l l u l a r potassium ions to the external surface of 
the muscle membrane. This l o c a l i s e d area of polarisation produces 
an inward current flow i n the adjacent depolarised membrane, r e s u l -
ting i n i t s repolarisation. Small constantly recurring potentials, 
which are l o c a l i s e d and non-propagated, are exhibited at the resting 
muscle f i b r e adjacent to the nerve endings^. These minute potentials 
are attributed to the release of small amounts of acetylcholine 
(Ach(l) ) from the synaptic v e s i c l e s of the nerve endings which 
diffuse across the synaptic c l e f t and are believed to combine momen-
t a r i l y with an unidentified receptor substance producing depolaris-
ation i n the region of the end plate. The small end plate potentials 
produced are not of s u f f i c i e n t amplitude to depolarise the muscle 
membrane and hence i n i t i a t e a muscle action potential^. 
2 
When the nerve impulse reaches the motor nerve ending a very 
large amount of Ach(.l) i s released and produces an end plate potential 
of s u f f i c i e n t amplitude to depolarise the muscle membrane around the 
end plate. This i n i t i a t e s the muscle action potential, which i s 
propagated as a wave of depolarisation along the muscle f i b r e surface. 
The Ach(l) released i s rapidly hydrolysed by the enzyme cholinesterase, 
and the potential difference across the muscle membrane i s then r e s -
tored-^. 
X" X" 
Me^JCH2CH2XGMe — Me3NCH2CH2OH 
(1) (2) 
i Cholinesterase 
Neuromuscular blocking agents are c l a s s i f i e d into two main 
divisions :-
( i ) those which act presynaptically., i . e . the drug acts at or 
around the motor nerve terminals 
( i i ) those which acli postsynaptically, i . e . the drug acts at the 
muscle end plate. 
PRESYNAPTIC NEUROMUSCULAR BLOCKING DRUGS 
Certain drugs are believed to int e r f e r e with the synthesis 
and storage of Ach(l)i Hemicholinium dibromide ( 3 ) ^ i n h i b i t s the 
synthesis of Ach(l) at the nerve endings and i t has been postulated 
that i t interferes with the transport of choline (2) to the s i t e of 
Ach(l) synthesis, r e s u l t i n g i n very l i t t l e Ach(l) being released. 
The block produced by hemicholinium dibromide (3) i s slow i n onset 
and i s antagonised by choline (2) and to a l e s s e r extent by analogues 
and esters of choline. 
3 
r 
COCH2N-CH2CH2OH 
Me 
X 
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Me 
COCH2|-CH2CH2OH 
(3) 
Triethylcholine (U)^  has a similar action to that of hemicholinium 
dibromide ( 3 ) . Both hemicholinium dibromide (3) and trie t h y l c h o l i n e 
(U) depress the motor end plate s e n s i t i v i t y to A c h ( l ) , but higher 
concentrations of the drugs are required to produce neuromuscular 
block by t h i s l a t t e r action than by t h e i r presynaptic e f f e c t ^ . High 
concentrations of es'arine tetraeihylammonium s a l t s ( 6 ) , d i g i t a l i s 
compounds (7) or sodium ion deficiency i n h i b i t Ach(l) synthesis, but 
i t has not been demonstrated that t h i s occurs at the neuromuscular 
3 
junction . 
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The r a i s i n g of the magnesium ion concentration or the 
lowering of the calcium ion concentration, i n the e x t r a c e l l u l a r plasma, 
blocks neuromuscular transmission by reducing the amounts of Ach(l) 
released a t the nerve endings^. 
Certain toxins, Clostridium botulinum*, puffer f i s h toxin"*, 
and the toxin secreted i n the s a l i v a r y glands of the Rocky Mountain 
wood t i c k , prevent release of Ach(l) from the nerve endings. The 
block resembles that exhibited by calcium ion deficiency. 
Large dosages of some a n t i b i o t i c s such as neomycin, strepto-
mycin and kanamycin produce neuromuscular block s i m i l a r to that produced 
by the depression of Ach(l) release, or by calcium ion deficiency^. 
5 
The a n t i b i o t i c s have l i t t l e c l i n i c a l value as neuromuscular blocking 
agents because large doses are necessary. 
A number of phenols, such as catecholamines, increase the 
quantity of Ach(l) released per nerve impulse and so accelerate the 
run down of Ach(l) stores. Some l o c a l and general anaesthetics, 
cardine glycosides, and 2,U-dinitrophenol are believed to reduce the 
release of Ach(l) by inh i b i t i o n of the selective sodium ion conduc-
tance change, responsible for the i n i t i a t i o n of the muscle action 
potential, r e s u l t i n g i n neuromuscular block^. 
POSTSYNAPTIC NEUROMUSCULAR BLOCKING DRUGS 
There are 'iwo main types of postsynaptic neuromuscular 
blocking agents :-
( i ) depolarising agents, which act by depolarising the end plate 
( i i ) non-depolarising agents, which act by occupying the receptor 
s i t e s on the motor end plate and so i n h i b i t the action of Ach(l) 
on them. 
Taylor and Nedergaard^ have emphasised that depolarising 
blocking drugs enter the muscle membrane through the motor end plate 
region. Non-depolarising drugs are unable to enter the muscle, but 
by combining with the receptors on the motor end plate, are able to 
prevent the action of Ach(l) and other depolarising drugs. Generally 
depolarising drugs have a slender f l e x i b l e structure whereas non-
depolarising drugs are r e l a t i v e l y large, bulky and r i g i d molecules. 
The potency of the two types of postsynaptic blocking drugs has been 
attributed to the r a t s of association and dissociation of the drug 
7 
with the receptors on the motor end plate , non-polarising drugs have 
a low rate of dissociation, whilst the depolarising drugs have a high 
r a t e . 
6 
DEPOLARISING NEUROMUSCULAR BLOCKING AGENTS 
This type of block i s due to the abnormally prolonged de-
polarisation i n the region of the end plate and has the following 
c h a r a c t e r i s t i c s . The block i s preceded by an increase i n motor 
a c t i v i t y due to i n i t i a l end plate depolarisation and there i s rto 
decrease i n the depolarising action of Ach(l) or anticholinesterase 
compounds, i n f a c t these have an additive e f f e c t , intensifying the 
block. The block may be reversed by the i n j e c t i o n of a non-
depolarising blocking agent, such as (+)-tubocurarine chloride ( 8 ) . 
However there i s no suitable antagonist of depolarising block as the 
dose i s too c r i t i c a l to be of c l i n i c a l value. 
neostigmine bromide (9), edrophonium chloride (10), decamethonium 
8 7 
dibromide (11) and succinylmonocholine dichloride (12) , a l l pro-
duce neuromuscular block by depolarisation of the motor end plate. 
Various drags, such as anticholinesterase compounds l i k e 
OCONMe OH 
Br 
3 
CI 
N Me? 
E t 
( 9 ) ( 10 ) 
2Br 
+ + 
Me3N (CH 2) 1 0N Me3 
( 11 ) 
CH 2C0 2(CH 2)2 N Me3 
2C1 
CH 2C0 2 (CH2)2N Me 
( 12 ) 
7 
I n man i n t r a - a r t e r i s l i n j e c t i o n s of Ach(l) have been observed to pro-
duce a transient stimulating effect followed by a b r i e f depressant 
effect and then by a more prolonged and l e s s marked depressant 
•9 
effect , which has the properties of a depolarising block. Ach(l) 
i s not used c l i n i c a l l y to produce neuromuscular block as huge doses 
are required, i t s actions are too widespread and f u l l i n h i b i t i o n of 
cholinesterase i s necessary. 
I n t r a - a r t e r i a l administration of choline (2) i n man produces 
depression of muscle action potentials evoked by nerve stimulation. 
Moderate degrees of block produced by choline (2) have properties of 
the depolarising type, but marked degrees of block have properties of 
the non-depolarising type^. 
The main disadvantages of the depolarising drugs are :-
( i ) there are no suitable antagonists should the need a r i s e 
( i i ) powerful muscle: fascic u l a t i o n s which precede the block may cause 
damage to the muscle f i b r e s and r e s u l t i n severe; deep muscle 
ache af t e r the operation. 
These disadvantages r e s t r i c t t h e i r use to short-lasting 
operations. 
NON -DEPOLARISING NEUROMUSCULAR BLOCKING AGENTS 
This type of block i s due to in h i b i t i o n of the depolarising 
action of the transmitter on the motor end plate. I t occurs without 
change i n the resting: potential of the muscle membrane and i s rever-
s i b l e by Ach(l) or an anticholinesterase compound. The block i s not 
preceded by an increase i n motor a c t i v i t y and there i s a decline i n 
the muscle action potentials i n response to two or more stimuli . 
The best known neuromuscular drug of t h i s type i s 
(+)-tubocurarine chloride ( 8 ) , which was probably f i r s t used by South 
American indians, who used the crude curare as an arrow poison. Crude 
curare contains a number of cl o s e l y related alkaloids that have a 
8 
similar action but attention is focused mainly on (+)^-tubocurarine 
chloride (8) a quaternary ammonium base. King^ separated 
(+)-tubocurarine chloride (8) from crude tubocurare, and later 
Wintersteiner and Dutcher^ isolated i t from a specific menisperm-
aceous plant, Chond<3dendron Tomentosum. 
Using n.m.r. spectroscopy, Everett et al have shown 
(+)-tubocurarine chloride (8) to contain one quaternary centre and 
not two as previous!Ly believed. ' 
AJ Me OMe OR Me 
2C1 
Me R 
R 
( 8 ) H 
(13 ) Me 
i 
The mechanism of the block produced by (+)-tubocurarine 
chloride (8) i s that, i t competes, i n a reversible manner, with Ach(l) 
for the occupation of the receptor sites on the motor end plate of 
the muscle, and hence blocks the transmitter action of Ach(l) thereby 
preventing depolarisation of the motor end plate. The motor end 
plate s t i l l retains i t s normal permeability to potassium ions and the 
muscle s t i l l responds to direct electrical stimulation. The block 
can be antagonised by depolarising neuromuscular drugs, such as Ach(l) 
and succinylcholine dichloride (12), the dose i s c r i t i c a l since such 
9 
drugs themselves produce neuromuscular block. The cooling of the 
muscle, the presence of excess potassium ions, adrenaline hydrochloride 
(lU), tetraethylammonium salts (6), and also anticholinesterase drugs 
antagonise the block by depolarisation. 
The main disadvantage, of (+)-tubocurarine chloride (8) as a neuro-
muscular blocking drug is that i t produces bronchoconstriction and 
lowering of the blood pressure, which i s due to the liberation of 
histamine (15). 
I n man the dimethyletiaer (13) of (+)-tubocurarine i s approximately 
twice as potent as (+)-tubocurarine chloride (8) i t s e l f , however 
(-)-tubocurarine i s roach less active. 
Calabash curare (another form of crude curare), the most 
active type, i s produced from different species of Strychnos and many 
alkaloids have been i.-solated from i t by Wieland et a l ^ j l H ^ Karrer et 
all5,l6,17, 
Battersby and Hodson"^ and various other workers. 
CI 
CHOHCH2NH2Me XX HO HO 
( Hi ) 
N O-CHoCHoNH 
H 
( 15 ) 
Of the f i f t y different compounds isolated only ten possessed 
10 
any curare l i k e a c t i v i t y i n particular-, C-toxiferine dichloride (16) 
was very active. By substitution of the quaternary methyl groups i n 
C-toxiferine dichloride (16) some derivatives were obtained of which 
19 
NjN'-diallyl-bis-nortoxiferine dichloride (17) was found to be the 
most useful c l i n i c a l l y . R 
CHpOH 
2 CI H 
V \ 
R 
R 
( 16 ) C H3 
( 17 ) -CH2CH = CH2 
Both C-toxiferine (16) and N,N'-diallyl-bis-nortoxiferiiie dichloride 
(17) have the advantage of high selectivity, no depression of blood 
pressure, no bronchoconstriction and no liberation of histamine (1$) 
compared to the other curare compounds. C-Toxiferine dichloride (16) 
has a f a i r l y long duration of action whilst that of N,N»-diallyl-bis-
nortoxiferine dichloride (17) i s f a i r l y short. 
The expense and d i f f i c u l t y of obtaining pure alkaloids from 
natural sources led to the efforts to prepare synthetic neuromuscular 
blocking agents. Three curarimetric drugs that have been introduced 
into c l i n i c a l practice are, li k e (+)-tubocurarine chloride (8), 
phenolic ethers. They are gallamine triethiodide ( 1 8 ) 2 0 , diplacine 
bromide ( 1 9 ) 2 1 and nediational iodide ( 2 0 ) 2 2 . 
11 
I 
OCH2CH2N Et 
OCHpCHp N Et 
0 CH:>CH2N Et 
(18 
2Br 
HO 3 OH CHoCHoO 0CH2 CH?—N HOHoC CHoOH 
( 19 ) 
< 
7 \ Me3N CH2CH20 CHo—CH OCH2CH2NMe3 
C3H? 
( 20 ) 
Gallamine triethiodidei (18) was the f i r s t synthetic relaxant to be i n -
troduced into c l i n i c a l practice and i s s t i l l widely used. I t i s about 
one f i f t h as potent as (+)-tubocurarine chloride (8) and has a much 
shorter duration of action. 
Some diquaternary compounds possessing a r i g i d structure were 
synthesised, so that the distance or the number of intermediate atoms 
12 
between the positively charged nitrogen centres were similar to those 
of (+)-tubocurarine chloride (8) or C-toxiferine dichloride (16). 
Medesan and Stoica^ found that fluorehe derivatives (21), 
which posses a r i g i d structure and seven interonium carbon atoms, 
possessed neuromuscular blocking activity greater than that of 
(+)-tubocurarine dichloride (8). 
Me-jN N Me3 
T 
OMe 
( 21 ) 
In the case of Malouetine dichloride (22) the two 
quaternary centres art; separated by ten carbon atoms. Although the 
centre of the moleculo i s r i g i d , the rotation of the side chain 
enables the distance between the two quaternary centres to vary from 
11 to 12.5 fi. I t s a c t i v i t y i s comparable to that of (+)-tubocurarine 
chloride (8). 
Me N Me3 \ CH 
CI 
H Me3N 
( 22 ) 
Because of the inconveniences associated with the depolaris-
ation mechanism of action of succinylcholine dichloride (12), many 
attempts have been made to develop short-acting neuromuscular drugs with 
a competitive action.. ihe f i r s t solution to the problem was pro-
vided by the synthesis of procedonium bromide (23) 26 
Br 
+ 
0 CH2CH2 N Mev> 
(CH 2)i 0 
I 
0 CH2CH2 N Me2 
C 
CH2COOC3H7 
Br + 
H2COOC3H7 
( 23 ) 
Subsequently, a series of compounds combining the properties 
of succinylcholine dichloride (12) with those of bistetrahydroisoquin-
?V PR olinium derivatives [2h) and bispiperidinium salts (25) were 
prepared. 
MeO 
MeO 
2 I " 
-( CH2 ) 3 02C—C02 ( CH 2) 3-^N. 
( 2k ) 
Me 2 X 
PhGOO - ^ I ^ ^ N (CH2) 20C (CH2) 3C0 (CH2) o ft 
( 25 ) 
Me 
OOGPh 
OMe 
OMe 
l i ; 
Me 
\ 
R —R 
N 
r R 
> h \ e 
( 28 ) 
Glover and Rowbottom^have prepared some azo-l,2,li-triazolium 
salts (28), the l,l-a:5obenzotriazolium salt (29) and also some 
3,3-dimethyl-l,l-azob<3nzimidazolium salts (30), which possessed some 
neuromuscular blocking acti v i t y . 
Me 
N 
N 
2 X 
/ 
ft 
( 29 ) 
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MR 
R 
H 
Me N 
2 X 
Ph 
p - Me OC^ H], 
R 
Me 
( 30 ) 
The remainder of this thesis describes a programme of work 
devised to investigate some of the structural features thought to be 
necessary for the desirable biological a c t i v i t y shown by the diquater-
nary compounds (27). 
The most prominent feature of the imidazopyridinium salts (27) 
is the diquaternary nature of the system, a characteristic repeatedly, 
though not always, encountered i n compounds having neuromuscular 
blocking a c t i v i t y . 
2'i 
Previously , the distance separating the positively charged 
centres has been suggested as important i n determining the degree of 
activity of diquaterniiry salts showing neuromuscular blocking properties. 
In the powerfully active iraLdas;o £l,2-a~J pyridinium salts (27) 
the bridgehead nitrogen atoms, which may be regarded as the most highly 
positive atoms, are separated by a t o t a l of seven bonds. 
The tetrazene linkage, a feature of imidazo £l,2-a] pyridin-
ium salts (27) i s believed to be f a i r l y labile i n biological systems 
and this was postulated as having some connection with the short-
17 
lasting property of the neuromuscular blocking agents. 
The synthesis of diquaternary compounds containing an azo 
linkage joining the following heterocyclic systems, methyl-2-
pyridylamine(I), and imidazori,5-a~| pyridine ( I I ) was attempted. 
Me 
N 
Me 
N 
N 
Me 
s + Me 
I . 
1 R A n -N N— 
R 
R 2 X ~ 
( I I ) 
18 
DISCUSSION 
0?he aim of this work was the synthesis of a series 
of diquaternary compounds incorporating a potentially biologically labile 
tetrazene linkage, the compounds to be prepared having, whenever possible, 
the following additional general features ( i ) two quaternary centres and 
( i i ) a seven bond length separation between positive centres. 
ks compounds having these requirements, the synthesis 
of diquaternary saltst incorporating methyl-2-pyridyl amine ( I ) and 
imidazo fl,5-a~| pyridine ( I I ) heterocyclic systems was undertaken. 
Me 
Me N 
H 
N 
N 
Me 
Me 
( I ) 
R 
1 2 X 1 R 
N H 
N Ph 1 R H R 
( I I ) Me H 
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METHH.-2-FYRIDYIAMINE DERIVATIVES ( I ) 
THE ATTEMPTED SYNTHESIS OF l,U-DIMETH7L-l,U-Dl(2-PIRIDYL)-2-TETRAZENE 
DIQUATERNARY SALTS (3U) 
The synthetic route proposed for. the introduction 
of the tetrazene linkage, was the oxidation of hydrazine (31) followed 
by the quaternisation of the resulting tetrazene (32) to afford the 
required diquaternary salt (-3U). 
e N 
•H NH') 
N N Me L J Me N N 
N 
31 ) 32 ) 
Me 
Me N N // 
Me 
N 
Me ( 3U ) 
Reagents proposed : i , Oxidising agent 
i i , MeX 
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2-Methylaminopyridine (35) was prepared using 
35 
essentially the same procedure as Tschitschibabin and Knunianz . 
Nitrosation of the 2-inethylaminopyridine (35) and the subsequent 
reduction of the resulting nitrosamine (36) gave the required 
hydrazine (31). 
Me Me 
NO N: NH 
( 36 ) / 35 
11 
Me 
( 31 ) 
Reagents used : i , NaN02 - HC1 at 0 
ii, Zn - CHoCOOH 
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Oxidation of the hydrazine (31)1 with saturated aqueous bromine gave 
the tetrazene (32) i n 39% yield, a small amount of the bromo substituted 
tetrazene (33) being also obtained. However^  treatment of the tetrazene 
(32) with methyl iodide gave 1-methyltetrazolo j[ 1,5-a] pyridinium iodide 
(37) instead of the expected tetrazene diquaternary salt (3U; X =1). 
Me 
N NHp 
31 
Me CHpBr N N N N 1 I 4 J N Me CHnBr 
N ( 33 ) ( 32 ) 
i i 
\ 
Me 
Me 
N Me N N 
I // I 
N Me 
( 3U ) Me ( 37 ) 
Reagents used : i , . saturated aqueous bromine 
i i , CH3I 
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The methyltetrazolop;;rridlnlum salt (37) was identical with a sample 
obtained by the treatment of tetrazolopyridine (39), obtained^ by 
the diazotisation of 2-h^ydrazinopyridine (38), with methyl iodide. 
NHNH 
\ 
N 
N 
( 39 ( 38 
i i 
/ C H 3 / 
N 
N 
I 
( 37 ) 
Reagents used : i , $OjL CH-jCOOH -NaN02 
i i , Mel 
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Quafcernisation of the tetrazene (32) with methyl fluorosulphonate 
likewise gave the corresponding 1-methyltetrazolo [ 1,5-aJ pyridinium 
salt, which was converted to the bromide (UO) bY ion exchange, instead 
of the expected tetrs.zene diquaternary bromide salt (3Uj X = Br). 
Me 
Me K N N \ 
N 1 
Me N 
Br 
( UO ) 32 ) 
i . i i 
Me. + 
Me N N // 
N——W Me 
2X 
Me 
( 3k ) 
Reagents used : i , CH^ OSOgF 
i i , Amberlite IRA U00(Br)-methanol 
2U 
Cyclisation of the tetrazene (32) to the tetrazolopyridinium bromide 
(UO), was better effected using boiling ethanolic hydrobromic acid. 
The isolation of 2-m3thylaminopyridine (35) from such a cyclisation 
confirmed the mechanism to be as that shown i n Scheme 1. 
Me 
N N 
Me ( 32 ) 
H 
Me 
NHCH3 
B:? 7
( UO ) ( 35 ) 
SCHEME I 
I n addition to establishing the position of allev-
iation of tetrazolo£l,5-a] pyridine the reaction also provides a route 
to the otherwise inaccessible l-aryltetrazolo[l,5-a] pyridinium salts. 
Accordingly the 1-phenyltetrazolo []1,5-a] pyridinium 
bromide (1*2j X= Br) was prepared by boiling the l,U-diphenyl-l,U-di(2-
pyridyl)-2-tetrazene (Ul) i n ethanolic hydrobromic acid and the system 
(U2j X = ClO^) further characterised by conversion to the perchlorate 
salt by ionexchange. 
25 
Ph — N 
I // | N N' 1 
Ph 
( Ul 
! Ph 
N \ 
N 
X 
U2 ) 
HBr Ethanol Reagents used 
The l-phenyltetrazolo[l,5-a] pyridinium perchlorate (l;2j I = ClOlJ, 
was prepared by r e f l u x i n g tetrazine (Ul) w i t h methyl iodide, the 
iodide (l|2j X = I ) being converted to the perchlorate s a l t by 
37 
ionexchange . 
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IMIDA-ZOri.g-aJ PYRIDINE DERIVATIVES ( I I ) 
2,2 -AZODtEDAZoll^a] FYRIDINIUM SALTS (53) - (57) 
The synthetic route proposed f o r the introduction of the 
tetrazene linkage was by d i r e c t N-amLnation of the imidazo[l,5-a] 
pyridines (h3) - (U7) followed by oxidation of the resu l t i n g 
N-amino compounds (I4.8) - (52) t o the required diquaternary t e t r a -
zenes (53) - (57). 
1 R 1 R 
NH 
R 
/ 1 1 R R 
( 1*8 ) H H ( U3 H H 
( U9 Ph H ( bh) Ph H 
( 50 .) H Ph ( U5 ) H Ph 
( 51 ) H Me ( U6 ) H Me 
52 ) Br Me ( U7 ) Br Me 
1 R 
R 
\ 2X 
N N 
r R 1 
53 ) H H 
5h H Ph 
Reagents used : i , H - Aminating agent ( 55 ) H Ph 
ii, Oxidising agent ( 56 ) H Me 
( 57 ) Br Me 
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Imidazo[l , 5-a] pyridine. (I4.3), 3-phenylimidazo[l ,5-a] pyridine (U5) and 
3-methylimidazojjL,5-aJ pyridine (1*6) were prepared using essentially 
the same procedure as that described by Bower and Ramage^. Cyclisa-
t i o n of the formyl - (59 ), the benzoyl-(60) and the acetyl-(6l) derivatives, 
of 2-pyridylmethylamine (58) was affected by reflu x i n g i n a mixture of 
phosphorus oxychloride and benzene, producing imidazo[l , 5-a] pyridine (U3), 
3-phenylimidazo[l ,5-a] pyridine(2i5) and 3-methylimidazo[l,5--a3 pyridine 
(U6) respectively. 
,CH,NH 
( 58 ) 
R 
( U3 ) H 
( us ) Ph 
( h6 ) Me 
i , HCOOH 
i i , benzoyl chloride 
i i i , Ac 20 and CH3COOH 
i v , P.OCI3 and benzene 
CH2NH-CDR 
R 
( 59 ) H 
( 60 ) Ph 
( 61 ) Me 
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l-Phenyljjnidazo[l,5-a3 pyridine (Ui) was prepared using the same pro-
cedure as that described by Glover and Vaughan . Phenyl-2-pyridylamine 
(63) was prepared by the reduction of 2-benzoylpyridine oxime (62) with 
zinc and ammonium hydroxide using the procedure described by Jochims^ 
f o r the preparation of diphenylmethylamine. Treatment of base (63) 
with formic acid gave the formyl derivative (6k) which underwent 
cycl i s a t i o n with phosphorus oxychloride i n b o i l i n g benzene yi e l d i n g 
the required l-phenylimidazo[l,5-a] pyridine (UU). r 
Ph Ph 
CH—NH 2 NOH 
dihydrochloride 
N 
( 62 ) ( 6; ) 
i i 
Ph Ph 
N 
IHNHCHO 
i i i 
( hh ) ( 6U ) 
Reagents used : i , Z.n - NH^ OH; HC1 
i i , HCOOH 
i i i , POCl-j - benzene 
N-AMENATICN PHOCEDUBES 
Chloramine and hydroxylamine-O-sulphonic a c i d ^ (H.S.A;) are 
the t r a d i t i o n a l reagents used f o r N-aminations. Recently Tamura et 
a l ^ l have successfully carried out N-aminations using O-mesitylene-
sulphonylhydroxylamine (M.S.H.) on a number of heterocyclic compounds, 
and found the y i e l d obtained to be much, higher than using H.S.A.^ 
(see table 1 ) . 
base M.S.H. 
Jfcyield N-amino s a l t 
H.S.A. 
£yield N-amirio s a l t 
pyridine 80 63 - 72 
2-picoline 9U 57 
2,6-lutidine 89 3U 
quinoline 67 32 
TABLE 1 
Wiemer et a l f a i l e d t o andnate adenine (6$) w i t h H.S.A., but with 
M.S.H. i n methanol l-amino-adeninium mesdtylenesulphonate (66), was 
obtained i n 65% y i e l d . 
NH SO 
t 
H2N 
V 
Me N Me 
N H H 
Me 
( 65 ) ( 66 . ) 
Reagents used : i , MSH./methanol 
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Koga et alm reported that the N-amination of thiazoles (67), 
benzothiazoles (68) and the imidazole (69) using M.S.H. gave the 
corresponding N-andnothiazolium (70), N-aminobenzothiazolium (71) and 
N-aminoimidazolium (72) compounds respectively i n good y i e l d s . 
R 
c Ft Yd \ (L 
NH 
( 70 ) 67 ) 
R R 
N 
NH 
71 ( 68 
C6H.GH C6H5CH ,2 
N Or Me Or Me N r 
NH2. 
Reagent used : i , M.S.H. 
N-Aminations have successfully been carried out by Glover and Row-
bottom^, i n high y i e l d , using M.S.H. and O-p-tblylsulphonyl-
hydroxylamine (T.S.H.) as the N-amLnating agents. Both M.S.H. and 
T.S.H-, are very powerful N-aminating agents giving good yiel d s . 
The T.S.H. i s less stable than M.S.H. but has the advantage of being 
derived from cheap and readily available p-toluenesulphonylchloride. 
The parent inddazopyridines (U3) - (U7) were a l l N-aminated 
i n good y i e l d using O-p-tolylsulphonylhj^droxylainine ( 7 5 ) ^ giving the 
N-amino salts (U8) - (52) respectively. The O-p-tolylsulphonyl-
hydroxylamine (75) was prepared by t r e a t i n g ethylacetohydroxamate (73) 
w i t h p-toluenesuiphonylchloride to produce the O-p-tolylsulphonyl-
hydraxamate (7U), which was then stinted with perchloric acid 
affording O-p-tolylsiilphonylhydroxylamine (75) which was extracted 
i n t o chloroform or methylene chloride.. 
Me Me 
C= NOSO NBH Me 
EtO Et 
( 73 ). ( 7h ) 
( 75 ) 
Reagents used : 1, p - tolylsulphonylchloride 
i i , 60$, HCIO^ 
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N NH2 
R1 R2 R1 R
2 
( U3 ) H H ( U8 ) H H 
( hh ) Ph H ( h9 ) Ph H 
( U5 ) H Ph ( 50 ) H Ph 
( U6 ) H Me ( 51 ) H Me 
( U7 ) Br Me ( 52 ) Br Me 
Reagents used : i , T.S.H./CHCl^ or :'?.S.H./CH2C12 
Oxidation of the phenyl substituted N-amino compounds (U9) 
and (50) w i t h saturated aqueous bromine gave, instead of the expected 
corresponding diquaternary tetrazene salts (5U) and (55)> the corres-
ponding tribromo-l,2-dihydroazeto[l,2-aJ pyridinium bromides (77) and 
(78). 
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-NH--
X" 
-Br 
•Br 
R 
( U8 ) H 
77 ) ( U9 ) Ph 
78 ) ( 50 ) H 
79 ) ( 51 ) H 
N-NH' 
R1 
Br 
Ph 
Br 
Br 
R 
Br 
Br 
Ph. 
Me 
iid(fl 1=Br;R 2=Ph) 
X ( 52 f ( 80 ) 
CH2C0Ph 
hydrobromide 
N s a l t 
( 81 ) 
Reagents used : i , saturated aqueous bromine 
i i , NaN02- HC1 
i i i , H^ /Pd charcoal - b a s i f i c a t i o n 
I n the early work of L o f f l e r the c y c l i s a t i o n of 2-^-haloethyl) 
pyridine (82) i s reported to give.pyridinium salts to which structure 
(83) was assigned U6 A number of such compounds appeared i n the 
l i t e r a t u r e ^ " - ^ and t h e i r s t r u c t u r a l assignments were generally 
accepted. Boekelheide et al**^ reported that the pyridinium bromide, 
prepared as described by L o f f l e r ^ , when subjected to hydrogenation 
over platinum, gave aii o i l b.p. 100°/0.2ram having a composition equi-
valent to (CjE^)x. The high b o i l i n g point of the o i l indicated i t 
to be the dimer (85) jaid determination of i t s molecular weight con-
firmed t h i s . Thus the most l i k e l y structure of L o f f l e r ' s pyridinium 
bromide i s (8k). 
3k 
CH2CH;!Br 
N 
Br 
\ 
83 82 ) 
o St 
2 Br" 
( 8U ) ( 85 ) 
Reagents used : i , Pt/H2 
The fused 6:U r i n g structure i s assigned to (77) and (78) on 
the basis of the absence of "D(N-H) bands i n t h e i r i n f r a r e d spectra, the 
conversion of the sal t (77 ) to the corresponding monoperchlorate and the 
hydrogenation and subsequent b a s i f i c a t i o n of (78) which yielded phenyl -2 -
pyridylmethylketone (81) isolated as the hydrobromide. 
The suggested course of. the reaction i s via i n i t i a l bromina-
t i o n at the free position of the imidazole r i n g followed by oxidation 
of the amino function yielding the amino-nitrene (86). The 1,U addition 
of the bromine i n the f i v e membered r i n g followed by nitrogen loss then 
gives the tribromo-l ,2-dihydroazeto-:pyridinium bromide as shown i n 
scheme 2. 
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B Br 
N—NH2 N NH 
7 N R X X / ( 86 ) 
Br -Br 
N 
Br X 
Q 
Br 
or Br 
Br Br X 
N 
Br X 
SCHEME 2 
Evidence of the i n i t i a l e l e c t r o p h i l i c bromination stage was 
obtained by the i s o l a t i o n of the bromo substituted N-amino s a l t (52) 
when 2-amino-3-methylimidazop.,5-aj pyridinium bromide (5l; X = Br) 
was treated w i t h saturated aqueous bromine. The 2-amino-l-bromo-
3-methylimidazo[l,5-'aJ pyridinium bromide (52) was also obtained by 
the N-amination of t i e l-bromo-3-methylimidazo [ l , 5 - a ] pyridine (1*7). 
Deamination of (52) i s i t h nitrous acid gave the nitroso compound (80) 
and f u r t h e r treatment of (52) with aqueous bromine gave the corres-
ponding tribromo-l,2--dihydroazetopyridinium bromide s a l t (79). 
Hydrogenat-JLon of the l,l J2-tribromo-2-phenyl-l,2-dihydro-
azetopyridinium bromJ.de (78) over palladium charcoal resulted i n the 
uptake of approximattsly two molecular equivalents of hydrogen and sub-
sequent b a s i f i c a t i o n gave phenyl-2-pyridylmethylketone (81) presumably 
vi a the intermediate monobromo compound (87) as shown i n scheme 3 . 
36 
Br 
Br OH HVPd OH 
Br :Br N 
+ >h Ph H Br Br 
Ph ( 87 ) ( 7 5 ) 
( 81 ) 
SCHEME 3 
The oxidation of the N-amino s a l t (U8) of the parent 
imidazopyridine (1*3) gave l,l,2,2-tetrabromo-l,2-dihydroazeto[l 32-a] 
pyridinium bromide (76) probably v i a i n i t i a l e l e c t r o p h i l i c bromination 
at both of the free positions of the f i v e membered r i n g . 
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KXPKKIMiajTAL 
A l l melting points were determined on a Kofler hot-stage and are 
uncorrected. N.m,.r. spectra were determined on a Perkin-Elmer 
R12A spectrometer. I . r . spectra were determined on a Perkin-
Elmer 237 spectrometer. Microanalyses were carried out by Dr. 
F.B. Strauss. 
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2-Methylaminopyridine (35) was prepared according to the method 
described by Tschitchibabin and Knuniang^. 
Powdered sodandde (39g) was covered w i t h absolute ether 
and a solution of 2-aminopyridine (9iig) i n absolute ether (l£) was 
slowly added dropwise. After the vigorous evolution of ammonia, 
the mixture was boiled under r e f l u x f o r l;5h on a water bath. A 
solution of dimethyl sulphate (63g) i n absolute ether (200 ml) was 
slowly added to the reaction mixture w i t h s t i r r i n g . After 
addition the reaction mixture was boiled f o r a further l h and then 
allowed to stand overnight. 
The mixture was washed with water and the aqueous 
washings extracted twice with ether. The combined ether extracts 
were then extracted with d i l u t e hydrochloric acid. The acid 
extracts were basified with 2%% aqueous sodium hydroxide, and then 
extracted with ether, the extract being dried over potassium 
hydroxide p e l l e t s . The solvent was removed under reduced pressure 
and the residual o i l (63g) was dissolved i n pyridine (l50ml) and 
then slowly treated with benzoyl chloride (I90g). After addition 
the mixture was heated on a water bath f o r 0.5h, cooled, and ice cold 10$ 
hydrochloric acid was added with thorough mixing. The acid solu-
t i o n was f i l t e r e d , and the f i l t r a t e was basified w i t h potassium 
hydroxide p e l l e t s , the o i l which separated was extracted i n t o 
ether. The extract was dried over potassium hydroxide p e l l e t s 
before f r a c t i o n a l l y d i s t i l l i n g the 2-benzoy]jnethylaminopyridine 
(Ul.Og, 20*) b.p. 19D°/10mm ( l i t 3 ^ . , b.p. 200°/lLmm). 
A mixture of 2-benzoylmethylaminopyridine (Ulg) i n 20^ 
hydrochloric acid solution was boiled under r e f l u x f o r 0.5h. 
After cooling the benzoic acid was f i l t e r e d o f f and the f i l t r a t e was 
basified with 2%% aqueous sodium hydroxide and then extracted 
39 
with ether. Fractional d i s t i l l a t i o n of the ether extract yielded 
2-methylaminopyridiQe (35) (12.lg, 57$) b.p. 82-8U°/7mm ( l i t 3 * . , b.p. 
90°/9mm). 
2-(N-Nitroaafliethyla:inino) pyridine (36) 
An ice cold solution of 2-raethylanriJiopyridine (35) (5g) 
i n 20$ hydrochloric acid (30 ml) was treated dropwise with a 
solution of sodium n i t r i t e (3.5g) i n water (10 ml). The reaction 
mixture was allowed to stand f o r 0.5h i n ice water before i t was 
treated.with ammonia. The liberated nitrosamine, which separated 
as an o i l , was extracted i n t o ether, the extract being dried over 
potassium hydroxide p e l l e t s . The solvent was removed under re-
duced pressure and the residual green yellow nitrosamine (36) was 
f r a c t i o n a l l y d i s t i l l e d (U.7g, 7h%) b„p„ 86-88°/5.5 mm ( l i t 3 5 . , 
b.p. 123-U°/30mm). 
l-Methyl-l-(2-pyridyl) hydrazine (31) 
A solution of the nitrosamine (36) (Ug) i n 80$ acetic 
acid (l5g) was added i n small portions to a s t i r r e d aqueous sus-
pension of zinc powder (l8g), the reaction mixture being main-
tained at iO - 15°. A f t e r addition of the nitrosamine solution, 
the reaction mixture: was s t i r r e d at room temperature f o r 3h before 
being f i l t e r e d and the residue being washed with 2M acetic acid. 
The combined washing's and f i l t r a t e were basified with 25$ sodium 
hydroxide solution. The separating o i l was extracted i n t o 
ether, the extract being dried over potassium hydroxide p e l l e t s . 
The solvent was then removed under reduced pressure and the 
residual o i l was f r a c t i o n a l l y d i s t i l l e d y ielding the pure 
hydrazine (31) (2.9g, 81$) b.p. 90-92'V8.5mm ( l i t 3 * . , b.p. 105°/10mm). 
ho 
1,U-Dlmethyl-1,U-di(2-pyridyl)^2-tetrazene (32) 
Saturated aqueous bromine (30 ml) was added i n 
bulk to a s t i r r e d solution of hydrazine (31) (2g) i n methanol (3 ml). 
The mixture was basified with 2M aqueous sodium hydroxide solution, 
t r i t u r a t i o n of the mixture yielded a white s o l i d which was f i l t e r e d 
o f f . Recrystallissition of the white s o l i d from methanol yielded 
the tetrazene (32) EIS colourless crystals (O.U3g, 22%) m.p. 137-138°. 
(Found: C,59.2; H, $.9; N, 3U.U. C^H-mNg requires 0,59.5} 
H, 5-856; N, 3h.7%). 
On r e c r y s t a l l i s a t i o n of the tetrazene (32) from methanol 
a small amount of mesthanol insoluble material was obtained. Re-
c r y s t a l l i s a t i o n of t h i s methanol insoluble product from chloroform 
gave a colourless compound m.p. 2U3°, i n very low y i e l d , a n a l y t i c a l 
data f o r which was consistent with structure (33). 
found: C, 36.0; H, 3.1; N, 21.5. Ci2H 1 2 B r2 N6 requires, 
C, 36.0; H, 3.0; M, 21.0*). 
l-Methyltetrazolo[l t5 - a 3 lyridinium iodide(37) prepared from 
tetrazene (32). 
A mixture of the tetrazene (32)(0.3g), methyliodide (3 ml) 
and methanol (3 ml) was boiled under r e f l u x f o r 17h and then cooled. 
Addition of ether to the reaction mixture caused p r e c i p i t a t i o n of 
the tetrazolo iodide (37) (0.06g, 3$%) which was f i l t e r e d o f f . 
Evaporation of the f i l t r a t e and r e c r y s t a l l i s a t i o n of :the residue 
from aqueous methanol gave the s t a r t i n g tetrazene (32.) (0.l6g). 
The y i e l d t o the reaction, i s before r e c r y s t a l l i s a t i o n and i s based 
on s t a r t i n g material consumed. The tetrazolo s a l t (37) was re-
cr y s t a l l i s e d from nitromethane-ether i n poor y i e l d m.p. 199°. 
(Found: C, 27.6; H, 2.95; N, 21.2. C^TSk requires, C, 27.5; 
H, 2.7; N, 21.W). 
Ul 
Tetrazolo Ll«5-aJ pyridine (39) was prepared according to the 
method described by Fargher and Furness36. 
2-Pyridylhydrazine (38)(lg)was dissolved i n £0j£ aqueous 
ace t i c a c i d (20 ml) and the resulting solution was cooled i n an 
i c e bath and then treated with sodium n i t r i t e (0.8g). The 
reaction mixture was neutralised with 2M sodium hydroxide solu-
tion and then extracted with chloroform. The solvent was 
removed under redused pressure and the residue obtained was 
c r y s t a l l i s e d from -water yielding the tetrazolo Tli5-a3 pyridine (39) 
as colourless c r y s t a l s (0.6g, $k%) m.p. 1$6° ( l i t ^ . , m.p. 159°). 
1-Methyltetrazolo [ l 1 5 - a ] pyridinium iodide (37) prepared from 
tetrazolo j^l,5-a] pyridine. 
A mixture of tetrazolo [ l,5>-a J pyridine (39) (0.2g) 
and methyl iodide (2 ml) was heated i n a sealed tube at 100° for 
a period of 20h. The r e s u l t i n g solution was evaporated under 
reduced pressure arid the residue obtained r e c r y s t a l l i s e d from 
methanol-ether yielding the iodide (37) as colourless c r y s t a l s 
(0.26g, 60$) m.p. 200°. 
(Found: C, 27.6; H, 2.7} N, 21.h%. Cffi^m^ requires C, 27-55 
H, 2.7; N, 21.1$). 
1-Methyltetrazolo Cl»5-a3 pyridinium bromide (UP) was prepared 
by using two d i f f e r e n t procedures :-
( i ) A mixture of the tetrazene (32) (0.29g) i n 
chloroform (5 ml) and methylfiuorosulphonate (2 ml) was heated 
on a boiling water l)ath for U - 5 minutes. The precipitate 
which separated was f i l t e r e d off and washed with ether. No 
suitable c r y s t a l l i s i n g solvent was found to r e c r y s t a l l i s e the 
precipitate obtained. A methanolic solution of the precipitate 
h2 
was eluted through an ion exchange column of Amberlite IRAhOO(Br). The 
volume of the methtinolic solution obtained after elution was 
decreased under reduced pressure. The remaining methanolic 
solution t~20ml) wtis boiled under ref l u x for 20h. . Ether was 
added to the r e s u l t i n g solution u n t i l i t became s l i g h t l y turbid 
and on cooling a s o l i d precipitated from the solution. The 
precipitate was f i l t e r e d from the solution and then r e c r y s t a l -
l i s e d from methanol-ether yielding the bromide (UO) as a pale 
yellow c r y s t a l l i n e s o l i d (0.09g, 35/0 m.p. 232°. 
(Found: C, 33-3; H, 3.1; N, 25.8. C^HyBrN^ requires C, 33.5; H, 3.3; 
N, 26.1g) 
( i i ) A mixture of the tetrazene (32) (O.lg), ethanol 
(20 ml) and hB% hydrobromic acid (0.07 ml) was boiled under 
refl u x for 2h. The reaction mixture was cooled and ether was 
added u n t i l p recipitation occurred. The precipitate was f i l -
tered off and r e c r y s t a l l i s e d from methanol-ether, yielding the 
bromide (UO) as a pale yellow c r y s t a l l i n e s o l i d (0.075g, &h%) 
m.p. 23li°. 
(Found: C, 33.3 J H, 3.1; N,' 2$.8. CgHyBrNk requires C, 33.5; 
H, 3.3; N, 26.1%) 
The f i l t r a t e was evaporated bo dryness under reduced 
pressure and the residue obtained dissolved i n water and b a s i f i e d 
with 10J6 aqueous sodium hydroxide solution. The basic solution 
was extracted with other, the combined ether extracts being dried 
over anhydrous sodium sulphate. The solvent was removed from 
the dried ether extract under reduced pressure and the residue 
obtained was treated with alcoholic p i c r i c acid which yielded 
the picrate of 2-methylaminopyridine (35) m.p. 189-190°, i d e n t i c a l 
with an authentic ssunple. 
2-(N-Nitrosophenylaniino) pyridine 
A solution of sodium n i t r i t e (8.5g) i n water (20 ml) was 
added dropwise to a vigorously s t i r r e d solution of 2-(phenylamino) 
pyridine (17.0g) i n concentrated hydrochloric acid (10 ml) immersed 
i n a water bath at 70°. The solution was cooled, the product 
f i l t e r e d off and r€!crystallised from methanol yielding 2-(N-nitroso-
phenylamino) pyridine as yellow prisms, m.p. 99° (l5i7g, 79%). 
( l i t 3 7 . , m.p. 99-100°, 80$). 
l-Phenyl-l-(2-pyridyl) hydrazine 
A solution of 2-(N-nitrosophenylamino) pyridine (U.Og) 
i n methanol (60 ml) and g l a c i a l acetic acid (lOg) was added drop-
wise over a period of l h to a s t i r r e d suspension of zinc powder 
(l8g) i n water (20 ml) immersed i n an i c e bath. The suspension 
was s t i r r e d for a further l h then f i l t e r e d and the residue washed 
with methanol (10 n i l ) . The combined f i l t r a t e and washings were 
ba s i f i e d with 2$% aqueous sodium hydroxide solution to pH 11 and 
extracted with ether (2 x 200 ml), each extract i n turn being, 
washed with water (15 ml)j the ether extract was evaporated and 
the re s u l t i n g aqueous mixture was extracted with ether (3 x £0 ml). 
The dried ether extract (anhydrous sodium sulphate) was 
evaporated under reduced pressure and the r e s i d u a l o i l was 
f r a c t i o n a l l y d i s t i l l e d yielding 1-phenyl-1 -(2 pyridyl), hydrazine 
( l . l S g , 31*) (b.p.135-137/1-5 ™ 0 ( l i t 3 7 . , b.p. 123°/0.6 mm., 2$%). 
1,U-Diphenyl-1,U-di(2-pyridyl)-2-tetrazene (Ul) 
Saturated aqueous bromine (30 ml) was added bulkwise 
to a solution of l-phenyl-l-(2-pyridyl) hydrazine (1.3g) i n 
methanol (3 ml). The reaction mixture was bas i f i e d with 10$ 
aqueous sodium hydroxide solution and on t r i t u r a t i o n gave an 
amber s o l i d which was f i l t e r e d off. R e c r y s t a l l i s a t i o n from 
methyl cyanide yielded the tetrazene (Ul) as colourless needles 
m.p. lUU° (decomp.) (0.2g, 16%) ( l i t 3 7 . , m.p. lU5° (decomp.), 19%). 
l-Phenyltetrazolop j ^ - a J pyridinium bromide (U2; X = Br) 
The tetrazene (Ul) (O.lg) was dissolved i n ethanol 
(20 ml) and k&% hydrobromic acid (0.11 ml) added, the mixture 
was boiled under ref l u x for 7h. The solution was cooled and 
ether was added u n t i l precipitation occurred. The precipitate 
was f i l t e r e d off but i t became a gum on the f i l t e r paper. The 
gum was r e c r y s t a l l i s e d from methanol-ether giving a brown s o l i d 
which contained s t a r t i n g meterial (Ul)• R e c r y s t a l l i s a t i o n of 
the brown s o l i d from nitromethane-ether gave the bromide 
(U2; X = Br) as a pale yellow c r y s t a l l i n e s o l i d i n very poor 
y i e l d , m.p. 23U°. 
(Found: C, U6.5; H, 3.8j N, 19.7. C^HpBrN^ ^ 0 requires, 
C, U6.2j H, 3.5i N, 19.6g). 
1-Phenyltetrazolod,5-al pyridinium perchlorate (U2; X = ClO^) 
The tetraisene (Ul) (0.08g), was dissolved i n ethanol 
(20 ml) and U8j? hydrobromic acid (0.2 ml) added, the mixture 
was boiled under reflux for 2.5h and then evaporated to dryness 
under reduced pressure. Attempts to r e c r y s t a l l i s e the residue from n i t r o -
methane and ether, gave a gum. The gum was dissolved i n 
chloroform (15 ml) snd treated with 70# perchloric acid (0.1 ml). 
The chloroform was removed under reduced pressure and the r e s i -
due was r e c r y s t a l l i s e d f i r s t from ethanol-ether and then 
nitromethane-ether yielding the perchlorate (U2j X = ClO^) as a 
pale yellow c r y s t a l l i n e s o l i d (0.02g, 31$) m.p. 2U1-2U20 ( l i t 3 7 . , 
m.p. 2U3-2l^°). 
2-Pyridylmethylamine (58) was prepared according to the method 
described by Craig and Hixon-'2. Zinc dust (280g) and g l a c i a l 
a c e t i c acid (280g) were added i n small portions to a s t i r r e d 
solution of 2-pyridinealdoxime (35-0g) i n ethanol ($25 ml) over 
a period of several hours. After standing overnight the 
suspended s o l i d was f i l t e r e d off and washed with alcohol. The 
combined f i l t r a t e and washings were concentrated under reduced 
pressure to a thick syrup, water was added and the evaporation 
repeated three successive times to remove as much of the a c e t i c 
acid as possible. An 80$ aqueous solution of potassium hydr- . 
-oxide was added to the residue and the o i l , which rose to the 
surface, was drawn off. The caustic suspension was subjected to 
steam d i s t i l l a t i o n to remove the retained base, the base being 
recovered by acidifying the d i s t i l l a t e with hydrochloric acid, 
evaporating off the -water and decomposing the residue with 80$ 
aqueous potassium hydroxide. The combined fractions of o i l 
were dried over potassium hydroxide p e l l e t s and then f r a c t i o n a l l y 
d i s t i l l e d yielding 2-pyridyl-methylamine (58) (l5.3g, 68$) 
b.p. 62 - 6J°/3.5 mm ( l i t * 2 . , b.p. 9±9l$ mm). 
1*6. 
2-Formamidomethylpyridine (59) was prepared by e s s e n t i a l l y the 
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same procedure as tliat described by Bovrer and Ramage-5 . 
A solution of 2-aminomethylpyridine (58) (8.29g) and 
98* formic acid (50 ml) was boiled under reflux for 3h. Excess 
formic acid was removed under reduced pressure and the residual 
o i l was f r a c t i o n a l l y d i s t i l l e d yielding the base (59) as a yellow 
o i l (8.87g, 85*) b.p. 1U2-11^1.5 mm ' ( l i t 3 8 . , b.p. l6Q-l6l°A mm.,, 7755) 
Imidazo[l»5-a] pyridine (U3) was prepared according to the method 
described by Bower s.nd Ramage 3 8. A s t i r r e d mixture of 
2-formamidomethylpyridine (59) (8.87g), phosphorus oxychloride 
(18 ml) and benzene (55 ml) was boiled under ref l u x for Ijh. 
Excess phosphorus ojcychloride and benzene were removed under 
reduced pressure and the residual o i l was decomposed with i c e 
water and b a s i f i e d with 2$% aqueous sodium hydroxide solution. 
The aqueous mixture was extracted with chloroform, the combined 
chloroform extracts being dried over calcium chloride. Frac-
tionation of the drisd extract gave the base (U3) (5.5g, 71$) 
b.p. 113-11572 mm ( L i t 3 8 . , b.p. 120-12573 mm., 71%). 
2-Aminoimidazo[l»5-a) pyridinium s a l t s (U8) 
"2-Aminoimidazo(l,5-aJ pyridinium-p-tolylsulphonate (U8j XKJyHySO^) 
To a solution of imidazo[l,5-a] pyridine (U3) (5.5g) 
i n chloroform (20 ml), T,S.Hj(0-p-tolyls'jlphonylhydroxylamine) 
5$ W/V i n chloroform (200 ml) was added i n bulk and the reaction 
mixture was s t i r r e d :?or 0.5h. Ether was added to complete 
precipitation of the product (l5g). A small amount of the 
U7 
P-tolylsulphonate sti l t (U8; X = CyRyJO^) ^"0.1g) was recrys-
t a l l i s e d from methanol-ether yielding colourless c r y s t a l s m.p. 
211* - 215°. 
(Found: C, 55.1; K, 5.2; N, 13.6, C^H-^N^O^S requires, 
c, 55.1; H, 5.0; N, 13.8$). 
2-Aminoimidazo|l >5-a] pyridinium bromide (U8; X = Br) 
A solution, of p-tolylsulphonate s a l t (1;8; X = C7H7SO3) 
(l5g), h8% hydrobrotrjic acid (10 ml) and methanol (150 ml) was 
boiled under reflux for h - 5 minutes. The solution was cooled 
and ether added to complete the precipitation . The bromide 
(U8; X = Br) was r e c r y s t a l l i s e d from methanol-ether as a colour-
l e s s c r y s t a l l i n e s o l i d (7.5g, 75$) m.p. 219 - 221°. 
(Found: C, 39.3; H, 3.8; N, 19.6. C ^ B r ^ requires, 
C, 39.3; H, 3.8; N, 19.6$). 
N.B. Overall y i e l d based on the starting imidazopyridine (U8) 
(5.5g). 
l,l,2,2-Tetrabromo-l,2-dihydroazetoQL,,2--a] pyridinium bromide (76) 
Saturated aqueous bromine (75 ml) was added bullewise to 
a solution of bromide (I4.8) (O.Ug) i n water ( 2 ml). The reaction 
mixture was s t i r r e d for 0.5h afte r which the red s o l i d which had 
separated was f i l t e r e d off, washed with water and dissolved i n 
absolute acetone. The solution was boiled under re f l u x u n t i l a 
white s o l i d precipitsited which was f i l t e r e d off and r e c r y s t a l l i s e d 
from acetone-U8$ hydrobromic a c i d yielding the bromide (76) as a 
colourless c r y s t a l l i t e s o l i d (0.21g, 22%) .m.p. 156 - 158°. 
(Found: C, 16.9; H, 1.1; N, 2.8. C-JE^BT^I requires, C, 16.8; 
H, 0.8; N, 2.8$) 
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2-Benzoylpyridlne Oxlme (62) was prepared using the procedure 
described by Huntress and Wa l t e r 6 2 . 
Sodium hydroxide (9.3g) was slowly added to a s t i r r e d 
solution of 2-benzcylpyridine (9.l5g) and hydroxylamine 
hydrochloride (5.0g) i n i n d u s t r i a l methylated s p i r i t - (20 ml). 
The mixture was boiled under ref l u x for 5 minutes, cooled and 
poured into a solution of concentrated hydrochloric acid 
(25 ml) and water (160 ml). The solution was neutralised to 
pheholphthalein with aqueous sodium hydroxide when the oxime 
(62) precipitated us a colourless s o l i d (8.7g, 88j€) ( l i t ., 
97$). 
Phenyl-2-pyridylroethylamine Dihydrochloride (63) was prepared 
e s s e n t i a l l y by the same procedure as that described by J.C. 
Jochims^ f o r the preparation of diphenylamine. 
A mixture of 2-benzoylpyridine oxime (62) (20g), zinc 
dust (30g), ammonium acetate (hg), i n d u s t r i a l methylated s p i r i t s 
(100 ml) and concentrated ammonium hydroxide (500 ml) was boiled 
under reflux f o r Uh. The reaction mixture was cooled and the 
so l i d f i l t e r e d off :and washed with ether. 50JC Aqueous sodium 
hydroxide solution (20.5 ml) was added to the f i l t r a t e and the 
res u l t i n g solution <3xtracted with ether. The combined washings 
and ether extracts were evaporated under reduced pressure giving 
a yellow o i l . The o i l was acidifed with concentrated hydro-
c h l o r i c acid and the re s u l t i n g mixture was then evaporated to 
dryness under reduced pressure yielding the dihydrochloride (63) 
25.5g, 92%) m.p. 2U5° ( l i t . 5 3 , m.p. 21*2 - 2UU°(decomp.)). 
h9 
N-(Phenyl-2-pyridylmethyl) formamide (6U) 
A solution of the pheryl-2-pyridylmethylamine 
dihydrochloride (63) (U5.5g) i n formic acid (1U0 ml) was boiled 
under r e f l u x for a period of 20h. Excess formic acid was 
removed under reduced pressure and the residue was b a s i f i e d with 
10$ aqueous sodium hydroxide solution. The liberated base (6k) 
was extracted into ether (3 x 250 ml) and the combined ether 
extracts were dried over anhydrous sodium sulphate. The solvent 
was removed under reduced pressure yielding a s o l i d residue. 
R e c r y s t a l l i s a t i o n of the residue from ether gave the base (6U) 
(21.lg, $6%) as yellow prisms, m.p. 75° ( l i t . 3 9 , m.p. 75-76°). 
l-Phenylimidazo[l,5-a] pyridine (hh) was prepared by e s s e n t i a l l y 
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the same procedure as that described by Glover and Vaughan . 
A magnetically s t i r r e d solution of the substituted 
formamide (6U) (21.lg), phosphorus oxychloride (UO ml) and ben-
zene (80 ml) was boiled under reflux f o r a period of 20h. 
Excess phosphorus axychloride and benzene were removed under 
reduced pressure, the residual o i l was decomposed with i c e 
water and the r e s u l t i n g mixture was b a s i f i e d with 25$ aqueous 
sodium hydroxide solution. The reaction mixture was then 
extracted with ether, the combined ether extracts were dried 
over anhydrous sodium sulphate. Evaporation of the dried 
extract under reduced pressure followed by r e c r y s t a l l i s a t i o n 
of the residue from ether gave base (kh) (I3.5g* 70$) as amber 
prisms m.p. 105 - 106° ( l i t . 3 9 , m.p. 102°). 
2-Amino-l-phenyliid.dazo[l >5-a] pyridirdum s a l t s (U9) 
2-Air±no-l-phenyliiiddazoD-,$-a] pvri<iiMum-p-tolylsulphonate (U9; 
X = C7H7SO3) 
To a solution of l-phenylimidazo£l,5-aJ pyridine (kh) 
(l.lUg) i n a minimum volume of methylene chloride, T.S.H. 5$ ^ /V 
i n methylene chloride (22 ml) was added i n bulk and the r e s u l t i n g 
mixture was s t i r r e d for 0.5h. Ether was added to complete pre-
c i p i t a t i o n of the product. RecrystaLLisation of the precipitate 
from methanol-ether yielded the p-tolylsulphonate {k9; XN37H7SO3) 
as a colourless c r y s t a l l i n e s o l i d (1.72g, 77%) m.p. 16U°. 
(Found: C, 62.2; H, 5.0; N, 10.5. C20H19N3O3S requires, 
C, 62.9; H, 5.0; lit, 11.0$). 
2-Amino-l-phenylimic'.azo[j.J5-a] pyridinium bromide (U9; X = Br) 
To a solution of l-phenylimidazo[l,5-a} pyridine (UU) 
(lOg) i n a minimum volume of methylene chloride, t.S.H. $% W/V 
i n methylene chloride (200 ml) was added i n bulk and the 
resulting mixture was s t i r r e d for l h . Ether was added to com-
plete precipitation of the p-tolylsulphonate s a l t (U9; J.=CJRJS0J) T 
which was f i l t e r e d off and converted to the bromide s a l t 
(U9j X = Br) by dissolution i n methanol (50 ml) and 48% hydrobromic 
acid (10 ml) followed by addition of ether u n t i l p recipitation 
occurred. R e c r y s t a l l i s a t i o n of the precipitate from methanol-
ether. yielded the bromide (I4.9; X = Br) as a colourless c r y s -
t a l l i n e s o l i d (10.9g., 73%) m.p. 217°. 
(Found: C, 53.9j H. U.5; N, IU.3. Ci3H 1 2BrN 3 requires 
C, 53-8; H, U.2; N., lh.5%) 
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l i2,2-Tribromo-l-phenyl-l J2^dihydroazeto[l J2-a] pyridinium s a l t s (77) 
,l,2,2-Tribromo-l-pheiffil-l,2-dihydroazetoCl,2-a] pyridinium bromide (77; 
X = Br) 
To a solution of bromide (US'; X = Br) (0.5g) i n water 
(2 ml), saturated squeous bromine (75 ml) was added i n 
bulk. The reaction mixture was s t i r r e d for l h after which the 
l i q u i d was decanted.from the red o i l , which had separated. 
After washing the o i l several times with water, the o i l was 
dissolved i n absolute acetone and the solution was boiled under 
reflux u n t i l p recipitation of a white s o l i d occurred. The 
solution was cooled and the precipitate was f i l t e r e d off and 
r e c r y s t a l l i s e d from methanol-ether yielding the bromide s a l t 
(77: X = Br) as a colourless c r y s t a l l i n e s o l i d (O.U6g, 53$) 
m.p. 187 - 188°. 
(Found: C, 31.h} H, 2.k; N, 2.8. Ci^oBr^N requires, 
C, 31.3; H, 1.8; I I , 2.8$) 
l,2,2-Tribromo-l-phenyl-l,2-dihydroazetoOL J2-a] pyridinium perchlorate 
(77;. X = ClO^) 
To a solution of the bromide s a l t (77; X = Br) (-~0.1g) 
i n methanol (10 ml) - 60$ perchloric acid G*"0.2 ml) ether was 
added u n t i l p r e c i p i t a t i o n occurred. The precipitate was f i l t e r e d 
off and r e c r y s t a l l i s e d from methanol-ether yielding the 
perchlorate s a l t (77'; X = ClO^) as a colourless c r y s t a l l i n e s o l i d 
m.p. 177 - 178°. 
(Found: C, 30.5; H, 2.1; N, 2.7. CjjHoB^ClNOk requires, 
C, 30.1; H, 1.8; N, 2.7$) 
N-Benzoyl-2-pyridyLiiethylamine (60) hydrochloride 
Benzoylchloride (2U.5 ml) was added i n small quantities 
to a solution of 2-pyridylmethylamine (58) (10.3g) i n methanol 
(57 ml) and 10$ aqueous sodium hydroxide solution (285 ml), the 
reaction mixture be:Lng shaken vigorously for several minutes 
af t e r each addition., The aqueous reaction mixture was extracted 
several times with ether. The combined ether extracts were 
evaporated under reduced pressure yielding a brown o i l which was 
acidifed with concentrated hydrochloric acid. The acid mixture 
was evaporated to dryness under reduced pressure. R e c r y s t a l l i s a -
tion of the s o l i d residue from ethanol yielded N-benzoyl-2-pyridyl-
methylamine (60) hydrochloride as colourless needles (23.5g, 9U$) 
m.p. 188 - 189° ( l i t . * 1 * , m.p. 189°). 
S-Phenylimidazotl^-a] pyridine (U5) was prepared by e s s e n t i a l l y 
the same procedure E.S that described by Bower and Ramage 3 8. 
An aqueousi solution of N-benzoyl-2-pyridylmethylamine (60) 
hydrochloride (23.5g;) was b a s i f i e d with 10$ aqueous sodium hydroxide 
solution and extracted with ether. The dried (calcium chloride) 
extract was evaporated under reduced pressure to givei N-benzoyl-2-
pyridylmethylamine (60). A magnetically s t i r r e d solution of base (60), 
phosphorus oxychloride (23 ml) and benzene (70 ml) was boiled under 
reflux for a period of 20h. Excess phosphorus oxychloride and 
benzene were removed under reduced pressure and the residual o i l 
decomposed with i c e water and the r e s u l t i n g mixture was b a s i f i e d 
with 25$ aqueous sodium hydroxide solution. The reaction mixture 
was extracted with ether, the combined ether extracts being dried 
over anhydrous sodium sulphate. Evaporation of the dried extract 
under reduced pressure followed by r e c r y s t a l l i s a t i o n of the 
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residue from ether gave base (U5) as pale yellow, prisms (ll.Og, 
51$) m.p. 109 - 110° ( l i t . 3 8 , m.p. 109°, 61$). 
2-Amino-3-phenylimidazo|jL,5-a] pyridinium s a l t s (50) ; 
2-Amino-3-phenylimidazoD-»5-aJ pyridinium-p-tolylsulphonate (50; 
X = C 7H7S0 3) 
To a solution of 3-phenylimidazo[l,5-aJ pyridine (U5) 
(5.2g) i n a minimum volume of chloroform, T.S.H. 5$ ^ /V i n 
chloroform (10U ml) was added i n bulk and the resulting mixture 
s t i r r e d for l h . Ether was then added to complete the p r e c i p i t a -
tion of the product which was f i l t e r e d off and washed with ether 
(7«5g* 73$). Re c r j r s t a l l i s a t i o n of the precipitate from methanol-
ether yielded the p-tolylsulphonate s a l t (50; X = C7H7SO3) as a 
colourless c r y s t a l l j j i e s o l i d m.p. 139 - lli0°. 
(Found: C, 62.7; E(. 5-1; N, 11.0. C20H10N3O3S requires 
C, 63.0; H, 5.0; K', 11.0$), 
2-Amino-3-phenylimid,azoO-,5-a] .pyridinium bromide (50; X = Br) was 
prepared by ( i ) dissolving the p-tolylsulphonate s a l t (50; X = 
C7H7SO3) i n ethanol - U8$ hydrobromic acid and adding ether or 
( i i ) conversion to bromide v i a ion exchange on (Amberlite 
IRA UOO ( B r ) ) . 
( i ) A solution of the p-tolylsulphonate s a l t (50; X = C7H7SO3) 
(11.2g) i n methanol (U0 ml) - 1*8$ hydro'bromic acid (2.5 ml) was 
boiled under r e f l u x for U - 5 minutes. The solution was cooled 
and ether added to ciamplete precipitation of product which was 
f i l t e r e d off and washed with ether. R e c r y s t a l l i s a t i o n of the 
precipitate from metlianol-ether yielded the bromide s a l t (50; X = Br) 
as a colourless c r y s t a l l i n e s o l i d (U.lg ;, U8$) m.p. 20U°. 
( i i ) A methanolic solution of the p-tolylsulphonate s a l t 
(50; Z = C7H7SO3) (0.5g) was eluted down an ionexchange column of Amber-
l i t e IRAUOO(Br). The volume of the methanolic solution obtained 
a f t e r elution was reduced by evaporation under reduced pressure 
Ether was added to completely precipitate a green s o l i d which 
was f i l t e r e d off arid washed with ether. R e c r y s t a l l i s a t i o n of 
the precipitate from methanol-ether yielded the bromide s a l t 
(50; X = Br) as a colourless c r y s t a l l i n e s o l i d (0.26g, 69$) 
m.p. 208°. 
(Found: C, $3-9; H, U.2; N, 1U.6. C 1 3 H 1 2 B r N 3 requires 
C, 53.8j H, U.2; S, Hi.5*) 
1,1 J2-Tribromo-2-ph'myl-l 32-dihy(^oageto[l 12-a| pyridinium bromide (78) 
was prepared from ( i ) p-tolylsulphonate (50; X = C7H7SO3) and 
( i i ) bromide (50; X = B r ) . 
( i ) To a solution of the p-tolylsulphonate (50; X = CyHySO^) 
(0.25g) i n water (5 ml), saturated aqueous bromine 
(30 ml) was added i n bulk. The reaction mixture was s t i r r e d 
for 0.5h afte r which the l i q u i d was decanted from the red s o l i d 
which had separated,. After several washings with water the 
s o l i d was dissolved i n absolute acetone and the solution was 
boiled under r e f l u x u n t i l the pr e c i p i t a t i o n of a white s o l i d 
occurred. The solution was cooled and the precipitate was 
f i l t e r e d off and r e c r y s t a l l i s e d from methanol-ether yielding the 
bromide s a l t (78) as a colourless c r y s t a l l i n e s o l i d (0.22g, 66$) 
m.p. 10U°. 
(Found: C, 31.5; H, 2.0; N, 2.5. C^oBr^N' requires 
C, 31.3; H, 1.8; N, 2.8$) 
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( i i ) To a solution of the bromide s a l t (50; X = Br) ! (0.5g) i n 
water (5 ml), saturated aqueous bromine (75 ml.) was 
added i n bulk. Tfc.e reaction mixture was s t i r r e d for 0.5h after 
which the l i q u i d was decantedfrom the red o i l which had separated. 
After several washings with water the o i l was dissolved i n 
absolute acetone and the solution boiled under ref l u x u n t i l a 
white s o l i d precipitated. The solution was cooled and the 
precipitate was f i l t e r e d off and r e c r y s t a l l i s e d from methanol-
ether giving the bromide s a l t (78) as a colourless c r y s t a l l i n e 
s o l i d (0.65g, 75$) m.p. 107 - 108°. 
(Found: C, 31.U; H, 1.8; N,.2.7. C^H^Br^N requires, 
C, 31.3; H, 1.8; I I , 2.8$). 
2-Acetaminomethylpyridine (61) was prepared by e s s e n t i a l l y the 
same procedure as that described by Bower and Ramage 3 8. 
A mixture of 2-pyridyimethylamine (58) (3.5g), a c e t i c 
anhydride (5.9 ml) End g l a c i a l a c e t i c acid (17.7 ml) were heated 
on a. boi l i n g water bath for 0.5h. Excess a c e t i c acid and 
ac e t i c anhydride were removed under reduced pressure; The 
r e s i d u a l o i l was f r a c t i o n a l l y d i s t i l l e d , yielding the :base (6l) 
as a pale yellow o i l (3.Ug, 70$) b.p. 130°/2 mm ( l i t . 3 8 , b.p. 
l60-l63°/5 mm). 
3- Methylimidazoll»5-J pyridine (1|6) was prepared by e s s e n t i a l l y 
the same procedure as that described by Bower and Ramage 3 8. 
2-Ac etaminomethylpyridine (6l) (lUg), phosphorus 
oxychloride (16 ml) jand benzene (I4.8 ml) were boiled under reflux 
for Uh, the mixture being magnetically s t i r r e d . Excess phos-
phorus oxychloride and benzene were removed under reduced 
pressure, the r e s i d u a l o i l being decomposed with i c e water and 
b a s i f i e d with 25$ aqueous sodium hydroxide solution. The reaction 
mixture was extracted with chloroform,, the combined chloroform 
extracts being dried over anhydrous sodium sulphate. Evaporation 
of the dried extract under reduced pressure followed by f r a c t i o n a l 
d i s t i l l a t i o n of the r e s i d u a l o i l yielded the base (U6) (8.6g, 70$) 
b.p. 110 - H U ° A . 5 mm ( l i t . 3 8 , b.p. 112 - nf/h mm, 62$). 
2-Amino-3-methylimidazoCl»5-aTpyridinium bromide (51; X = Br) 
To a solution of 3-methylimidazo[l,5-aj pyridine (U6) 
(2g) i n a minimum volume of chloroform, T.S.H. 5$ W/V i n chloro-
form (6U ml) was added i n bulk and the re s u l t i n g mixture s t i r r e d 
f o r l h . Ether was added to complete the precipitation of the 
p-tolylsulphonate s a l t (51; X = C7H7SO3), which aft e r r e c r y s -
t a l l i s a t i o n from methanol-ether had m.p. 165°. The p - t o l y l s u l -
phonate (51J I = C-jHySO^) was converted to the bromide s a l t 
(51; X = Br) by dissolution i n ethanol (20 ml) - U8$ hydro-
bromic acid (1 ml) followed by addition of ether u n t i l p r e c i p i -
tation occurred. R e c r y s t a l l i s a t i o n of the precipitate from 
methanol-ether yielded the bromide s a l t (5lj X = Br). (1.6g, U6$) 
m.p. 221°. 
(Found: C, Ul.8; H, U.6; N, 18.2. ^8^10^r^3 requires 
C, U2.1; H, U.U; N, 18.U$). 
2-Ainino-l-bromo-3-mei^hylimidazoCL,5-a] pyridinium bromide (52; X=Br) 
To a solution of bromide s a l t (51; X = Br) ( l g ) i n 
water (U ml), saturated aqueous bromine (100 ml) was added i n 
bulk and the r e s u l t i n g mixture was s t i r r e d f o r 2 - 3 minutes. 
The s o l i d which separated was f i l t e r e d off and washed several 
times wi-tti water. The s o l i d obtained was r e c r y s t a l l i s e d from 
methanol and gave the bromide s a l t (52; X = Br) (0.32g, 23$) 
m.p. 223°. 
(Found: C, 31.7; H., 2.8; N, 13.9. CgHpBr^ requires C, 31.3; 
H, 3.0; N, 13.1%). 
l-Bromo-3- methylimidazoD- t$-a] pyridine {hi) hydrobramide 
A solution of bromine (1.5 ml) i n methanol (10 ml) was 
added dropwise to a stirred solution of 3-methylimidazojl,5-aJ 
pyridine (1*6) (1.67g) i n methanol (10 ml). After the addition 
was complete the reaction mixture was stirred for a further Ih 
at room temperature. Ether was then added to precipitate the 
hydrobromide of the base (U7). The hydrobromide of the base (U7) 
was recrystallised from methanol-ether as pale yellow prisms 
(2.76g, 1$%) m.p. 179° (decomp.). 
(Found: C, 33.1; H, 3.2; N, 9.5. CsH8Br2N2 requires C, 32.9; 
H, 2.8; N, 9,6%). 
l-Bromo-3-methylimidazoD.,5-a]l pyridine {hi) 
The hydrobromide of base {hi) (0.5g) was dissolved i n 
water and basified with 2$% aqueous sodium hydroxide solution. 
The aqueous solution was extracted with ether, the ether extract 
being dried over anhydrous sodium sulphate. The ether was 
removed under reduced pressure leaving a solid residue. Vacuum sub-
limation of the residue yielded the base (i;7) as a yellow crystal-
line solid (0.35g, 9<#) m.p. 96°C. 
(Found: C, US.8; H, 3.U; N, 13.3. CsHyBri^ requires 
C, U5.5; H, 3.3; N, 13.3*).. 
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2-Amjjao-l-bromo-3-methyllmidazo[l^-e3 pyridinium bromide (52; X = Br) 
The hydrobromide of base (U7) (1.7g) was dissolved i n water 
and basified with 2l'<% aqueous, sodium hydroxide solution. The 
aqueous solution WBEI extracted with ether, the ether 'extract drieH 
over anhydrous sodivim sulphate. The solvent was removed under 
reduced pressure lesiving the yellow base (U7). The base (U7) 
was dissolved i n chloroform (10 ml) and T;S.H. 5>jt ^/V i n chloro-
form (UO ml) added i n bulk and the reaction mixture was stirred 
for Ih. Ether was added to completely precipitate the 
p-tolylsulphonate salt (52; X = C7H7SO3) which after recrys-
t a l l i s a t i o n from methanol-ether had m..p. 216° decomp. The 
p-tolylsulphonate salt (52j X = C7H7SO3) was converted to the 
bromide (52; X = Br) by dissolution i n methanol (UO ml) - hQ% 
hydrobromic acid {h ml) followed by the addition of ether u n t i l 
precipitation occurred. Recrystal1i sation of the precipitate 
from methanol yielded the bromide salt (52; X = Br) (0.6lg, 
3h%) m.p. 223°. 
(Found: C, 31.5; H, 2.8; N, 13.6. CQH^B^^ requires 
C, 31.3; H, 3.0; N, 13.758). 
1,1,2-Tribromo-2-methyl-l,2-dihydroazeto (j.,2-aj. pyridinium bromide (79) 
The bromid'3 salt (52; X = Br) (0.2g) was dissolved i n 
50JC aqueous methanol (5 ml) and saturated aqueous bromine 
(30 ml) was added i n bulk. The reaction mixture was stirred for 
0.5h. after which the l i q u i d was decanted from the red o i l which 
had separated. The o i l was washed with water several times and 
then dissolved i n absolute acetone and the solution was boiled 
under reflux u n t i l a white solid precipitated. Recrystallisation 
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of the solid from methanol-ether yielded the bromide (79) as a 
crystalline solid (O.OSg, 17%) m.p. 11*2 - 11*3°. 
(Found: C, 22.2; H, 1.8j N, 3.h. C^Bi^N requires, C, 22.0; 
H, 1.6; N, 3.2%), 
l-Nitroso-3-methylimidazo[l 15-a] pyridine (80) 
Deamination of bromide (fj2; X = Br) treatment with 
nitrous acid followed by hypophosphorous acid resulted i n 
simultaneous nitrosation to give base (80). 
To an ice cold solution of bromide ($2; X = Br), (0.2g) 
i n concentrated hydrochloric acid (20 ml), an ice cold solution of 
saturated sodium n i t o i t e (2 ml) was added over a period of ten 
minutes, the solution was stirred for a further 0.£h at room 
temperature. Hypophosphorous acid ( 3 ml) was added to the 
solution and the solution was stirred for a further l h , and then 
chilled at 0° for 3h. . The 
solution was then basified with 2M sodium hydroxide solution and 
then extracted with ether. The ether was removed from the dried 
(sodium sulphate) extract under reduced pressure, the residue 
obtained was recrystallised from ether yielding base (80) in poor 
yield m.p. 89°. 
(Found: C, 59.U; H, h.3; N, 26.3 . C8H7N30 requires 
C, 59.6; H, U.U; N, 26.1%). 
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Phenyl-2-pyridyLnethylketone (81) hydrobromide 
The brond.de salt (78) (0.5g) was dissolved i n ethanol 
(75 ml) and 10J8 palladium-charcoal (0.l5g) added to the solution. 
The mixture was hydrogenated at atmospilieric pressure u n t i l the 
uptake of hydrogen ceased. The reaction mixture was then 
f i l t e r e d and the solvent removed under reduced pressure. The 
residue was dissolved i n water, basified with 2M sodium hydroxide 
solution and then e-bher extracted. The ether was removed from 
the dried (sodium sulphate) extract under reduced pressure and 
the residue obtained dissolved i n ethanol (20 ml) - U8/6 HBr (0.5 ml), 
ether was added and the precipitate was f i l t e r e d off. The 
precipitate was reciystallised from ethanpl-ether yielding the 
hydrobromide salt (O.Ug, 15$) m.p. 157 - 158°. 
Phenyl-2-pyridylmethylketone (81) hydrobromide was prepared 
essentially by the same procedure as that described by Goldberg et 
Phenyl lithium (0.105 mole) was prepared i n absolute 
ether (125g) from lithium and bromobenzene. 2-Picoline (5g) 
was added to the phenyl lithium mixture over a period of ten 
minutes, the mixture then being boiled under reflux for 30 minutes. To 
the rapidly stirred solution, a solution of ethylbenzoate (U.3g) 
i n absolute ether (2> ml) was added, over a 20 minute period so 
that the ether refluxed rapidly, the mixture was then boiled under reflux 
for 0.5h on a water bath. Water (25 ml) was added slowly and the 
resulting mixture poured on to 6N hydrochloric acid (25 ml) and 
crushed ice (lOOg). The ether phase was extracted several times 
with 6N hydrochloric acid. The combined acidic extracts were 
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treated with 20# aqueous sodium hydroxide solution u n t i l the 
solution remained E i l i g h t l y acidic, sodium bicarbonate was then added 
u n t i l the solution was basic. 
The aqueous solution was extracted with ether, the 
combined ether extracts were dried over anhydrous sodium sulphate. 
Evaporation of the dried ether extract under reduced pressure 
yielded an o i l which was fractionally d i s t i l l e d giving 
phenyl^2-pyridyljiethylketone (81) b.p. 155 - l 6 0 ° / 3 mm ( l i t . ^ , b.p. 
ll£ - 153°/ 2 mm). 
A small amount of phenyl-2»p;yridylmethylketone (81) 
was dissolved i n methanol (10 ml) - h&% hydrobromic acid (0.1 ml) 
and ether was added u n t i l precipitation occurred. The 
precipitate was recitystallised from methanol-ether yielding the 
hydrobromide of base (81) as a crystalline solid m.p. 157 - 158° 
( l i t . 5 6 , m.p. 156 - 157°) . 
Ethylacetimidate Hydrochloride was prepared according to the 
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method 'described by McElvain and Nelson-''. 
Dry hydrogen chloride was passed into an ice cold 
solution of dry methyl cyanide (20g) i n absolute ethanol (22g) 
and absolute ether (20g) for a period of Uh. The solution was . 
allowed to stand overnight at 0 ° . The reaction mixture 
was then cooled to -80° ( i n a liquid nitrogen bath) and then 
treated with ether u n t i l the product crystallised out as colour-
less prisms, which were f i l t e r e d off and washed with ether (52g, 
81$) m.p. 110° ( l i t . ' 8 , m.p. 98 - 100° (decomp.)). 
Ethylacetohydroxama:.e (73) was prepared according to the method 
to 
described by Millen and Waters'^ . 
Ethylacev.imidate hydrochloride (l5g) was added i n 
small portions to a stirred solution of potassium carbonate 
(3h.5g) i n water (75' ml) immersed in an ice bath. The mixture 
was stirred for a further 10 minutes and then extracted with 
ether (3 I 50 ml). The combined ether extracts were shaken 
with a solution of hydroxylamine hydrochloride (10.65g) i n water 
(37.5 ml) for 5 minutes, and then the layers were separated. 
The aqueous phase was extracted again with ether (2 x h0 ml) and 
the combined ether phases were dried over anhydrous sodium sulphate. 
Evaporation of the dried ether extracts under reduced pressure 
gave ethylacetohydraicamate (73) as a colourless o i l (6-2g, 66%) 
( l i t . 6 0 , m.p. 25 - 2 6 ° ) . 
Ethyl-O-p-tolylsulphonylacetohydroxamate (7U) 
An ice cold solution of freshly prepared ethylaceto-
hydroxamate (73) (8.J!g) and triethylamine (8.2g) in dimetLyl-
formamide (55 ml) wai-i treated with p-tolylsulphonylchloride 
(l5.1g) over a period of 10 minutes. The resulting mixture 
was stirred at room temperature for a further 2h. The 
triethylamine hydrochloride, which had precipitated from the 
reaction mixture, was f i l t e r e d off and washed with ether. 
Evaporation of the ether washings and the combined f i l t r a t e , 
under reduced pressure, followed by addition of the residual 
solution to ice cold water (500 ml) gave the hydroxamate (7U) 
(12g, 58/K) which crystallised from aqueous methanol as colourless 
prisms m.p. 70° ( l i t . 0 1 , m.p. 69 - 71°). 
63 
O-p-tolylsulphonyl hydroxy lajriine (75) was prepared according to 
the procedure described by Glover and Rowbottom61. 
A suspension of the hydroxamate (7U) (2.0g) i n 60* 
perchloric acid was stirred at room temperature when the hydroxamate 
dissolved and a colourless solid separated. The suspension was then 
poured on to crushed ice and the mixture extracted with methylene 
chloride. Evaporation of the dried (l^SO^) extract gave the 
hydroxylamine (75) (I . 0 5 g , 7h%), m.p. 39° ( l i t . 6 1 , m.p. U0°, 
76*). 
The product was too unstable for recrystallisation but 
could be stored for about one week in chloroform or methylene 
chloride. On standing ammonium p-tolyl-sulphonate slowly 
precipitates. 
6U 
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Quaternary salts 
Yie ld 
(%) 
Found (%) Rqd. (%) 
Product X M.p. (°C) Cryst. solvent C H N C H N 
(13) 
(10) 
(10) 
80 
28 
26 
143 
172—174 
172—174 
M e O H - E t s O 
E t O H - E t , 0 
E t O H - E t . O 
49-5 
40-1 
4-8 
4-3 
12-2 
11-8 
49-3 
39-9 
4-7 
4-2 
12-3 
116 
(14) 82 155—156 E t O H 50-9 4-96 9-8 50-7 4-6 9-9 
(7) J 38 216—217 MeNO, 40-8 2-5 17-4 40-8 2-8 17-3 
(7) G O , » 31 243—244 M e N O , - E t j O 44-0 3-3 18-7 44-5 3-1 18-9 
(7) 
(6) 
l ir 
i:> 39* 
234 
199 
M e N O , - E t . O 
M e N O , - E t s O 
46-2 
27-6 
3-5 
2-96 
19-6 
21-2 
46-6 
27-5 
3-8 
2-7 
19-7* 
21-4 
(6) 
(6) ]3r 
60 
84 
200 
234 
M e O H - E t , 0 
M e O H - E t a O 
27-6 
33-5 
2- 7 
3- 3 
21-4 
2605 
27-5 
33-3 
2-7 
3 1 
21-4 
26-8 
Reactants 
(9) (0-2 g) + M e O S O a F • 
(13) (0-4 g) + 48% H B r (5 m l ) • 
(9) (0-5 g) + Mel (3 ml) and MeOH 
(3 m l ) ' 
2-Anilinopyridine (0-86 g) in CHC1, 
(10 ml) + M e O S O £ F (0-67 g) *" 
(4) (0-24 g) + Mel (3 ml) and MeCN 
(3 ml)* 
(4) (0-08 g) in E t O H (20 ml) and 48% 
H B r (0-2 ml) > 
(3) (0-3 g) + Mel (3 ml) and MeOH 
(3 ml) ' 
(8) « (0-2 g) + Mel (2 ml) • 
(3) (01 g) in E t O H (20 ml) and 48% 
H B r (0-07 ml) «* 
• The reaction mixture was maintained at 0 °C until all the solid had dissolved. Trituration then gave the fluorosulphate which 
was filtered ofi. 1 The solution was boiled under reflux for 1 h and evaporated to dryness under reduced pressure. The residue was 
then recrystallized. 0 The solution was boiled under reflux overnight and evaporated to dryness under reduced pressure. The residue 
was then boiled with 16% H B r (5 ml) for 5 min and again evaporated to dryness. The residue was then recrystallized. * Added drop-
wise to the stirred solution. The product sepaiated and was filtered off. ' The solution was boiled under reflux overnight and 
then cooled, and the product was filtered off. ' The solution was boiled under reflux for 2-5 h and then evaporated to dryness under 
reduced pressure. Attempts to recrystallize the residue from nitromethane-ether gave a gum which was dissolved in chloroform 
(16 ml) and treated with 70% perchloric acid (3 drops). The chloroform was then evaporated off and the residue recrystallized first 
from ethanol-ether arid then from nitromethane-ether. ' Also obtained from the iodide by treatment with 70% perchloric acid. 
* For the hemihydrate. < The solution was boiled under reflux for 17 h and then cooled. Addition of ether precipitated the crude 
product which was filtered off. Evaporation of the filtrate and recrystallization of the residue from aqueous methanol gave the 
starting tetrazene (0-16 g). > The two samples were identical (i.r. spectra and mixed m.p.). * Before recrystallization and based on 
starting material consumed. 1 The reaction mixture was heated in a sealed tube at 100 C for 20 h. The solution was then evapor-
ated and the residue recrystallized. "* The reaction mixture was boiled under reflux for 2 h. The solution was then cooled and 
ether added to incipient precipitation. The bromide which separated on cooling was filtered off and the nitrate evaporated to 
dryness. The residuej was basified and extracteel with ether. Evaporation of the dried extract and treatment of the residue with 
alcoholic picric acid gave 2-methylaminopyridine picrate, m.p. 189—190°, identical with an authentic sample. 
• R . G . Fargher and R . Fumess, / . Chem. Soc.., 1916, 688. 
